Two red-hot topics for primary care clinicians, presented by the Johns Hopkins University School of Medicine. The first educates clinicians on the significant challenges in revising the National Cholesterol Education Program Adult Treatment Panel guidelines and provides balanced recommendations. The second educates primary care clinicians on the evidence-based treatment of heart failure and provides guidance for commonly encountered clinical dilemmas.
Click here for more information on the series.
Breakthrough cancer pain (BTCP) is a common occurrence in cancer patients that can be treated by a number of immediate-release (IR) opioids, some of which are specifically labeled for this use (i.e., IR fentanyl). However, the predominant use of breakthrough pain products, particularly the IR fentanyls, is off-label for noncancer pain-related diagnoses. Education is needed around the safe use of opioid analgesics and, more specifically, the IR fentanyl medications for BTCP. This educational program is specifically designed to support this objective.
Click here for a full listing of activities.
is free, fast, and customized just for you!
Already a member?Sign In Now »